Imamura S, Hirai K, Hirai A
GIP receptor antagonists: Although agonism is currently dominant in approved therapies, antagonists are being explored in animal models for obesity, because blockade of GIP signalling may limit lipid storage and adiposity under certain conditions
The formulary will show coverage status, tier placement, and whether prior authorization is required
Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR
JCI Insight 7:863
Each of these strategic domains connects to Wellstar medical service lines to bring to bear the deep expertise and broad bench of resources needed to identify pertinent needs, relevant partnerships, and viable programs